Open Access
Open access

Exploration of Targeted Anti-tumor Therapy

Open Exploration Publishing
ISSN: 26923114

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q2
SJR
0.692
CiteScore
2.8
Categories
Oncology
Cancer Research
Areas
Biochemistry, Genetics and Molecular Biology
Medicine
Years of issue
2020-2023, 2025
journal names
Exploration of Targeted Anti-tumor Therapy
Publications
62
Citations
714
h-index
13
Top-3 countries
Italy (23 publications)
USA (12 publications)
India (7 publications)

Most cited in 5 years

Top-100

Citing journals

5
10
15
20
25
30
35
Show all (70 more)
5
10
15
20
25
30
35

Citing publishers

20
40
60
80
100
120
140
160
180
Show all (26 more)
20
40
60
80
100
120
140
160
180

Publishing organizations

1
2
3
4
5
6
7
Show all (57 more)
1
2
3
4
5
6
7

Publishing organizations in 5 years

1
2
3
4
5
6
7
Show all (57 more)
1
2
3
4
5
6
7

Publishing countries

5
10
15
20
25
Italy, 23, 37.1%
USA, 12, 19.35%
India, 7, 11.29%
France, 5, 8.06%
United Kingdom, 5, 8.06%
Australia, 4, 6.45%
China, 3, 4.84%
Pakistan, 3, 4.84%
Switzerland, 3, 4.84%
Germany, 2, 3.23%
Japan, 2, 3.23%
Belarus, 1, 1.61%
Portugal, 1, 1.61%
Belgium, 1, 1.61%
Israel, 1, 1.61%
Iran, 1, 1.61%
Spain, 1, 1.61%
Mexico, 1, 1.61%
New Zealand, 1, 1.61%
Poland, 1, 1.61%
Republic of Korea, 1, 1.61%
Singapore, 1, 1.61%
5
10
15
20
25

Publishing countries in 5 years

5
10
15
20
25
Italy, 23, 37.7%
USA, 12, 19.67%
India, 7, 11.48%
France, 5, 8.2%
United Kingdom, 5, 8.2%
Australia, 4, 6.56%
China, 3, 4.92%
Pakistan, 3, 4.92%
Switzerland, 3, 4.92%
Germany, 2, 3.28%
Japan, 2, 3.28%
Belarus, 1, 1.64%
Portugal, 1, 1.64%
Belgium, 1, 1.64%
Israel, 1, 1.64%
Iran, 1, 1.64%
Spain, 1, 1.64%
Mexico, 1, 1.64%
New Zealand, 1, 1.64%
Poland, 1, 1.64%
Republic of Korea, 1, 1.64%
Singapore, 1, 1.64%
5
10
15
20
25